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Abstract 
Background: The aim of this study was to investigate whether the prior consumption 
of 200mg of pure caffeine affected neuropsychological test scores in a group of elderly 
participants aged over 60 years.  Method: Using a double blind placebo vs. caffeine design, 
participants were randomly assigned to receive 200mg of caffeine or placebo.  A 
neuropsychological assessment testing the domains of general cognitive function, processing 
speed, semantic memory, episodic memory, executive function, working memory and short-
term memory was carried out. Results: Significant interaction effects between age, caffeine 
and scores of executive function and processing speed were found; participants who had 
received caffeine showed a decline in performance with increasing age.  This effect was not 
seen for participants who received placebo. Conclusion: The results highlight the need to 
consider and control prior caffeine consumption when scoring neuropsychological 
assessments in the elderly which is important for accuracy of diagnosis and corresponding 
normative data.  
 
 




Previous longitudinal studies have investigated the relationship between habitual 
coffee consumption and cognitive performance [1,2,3]. Prior caffeine consumption in the 
period just before the time of testing is less well studied. If caffeine does affect test scores 
this will have implications for the accuracy of scoring these tests and consequently any 
interpretations made.  Previously Lesk and Womble [4] found strong interactions between 
prior consumption of 200mg of caffeine (approximately the same amount of caffeine in one 
strong cup of coffee) or placebo and, phonological priming, on the tip-of-the-tongue state in 
both young participants [4] and in a patient with anomic aphasia [5].  Lesk et al. [6] then 
investigated the effect of prior caffeine intake on neuropsychological test scores in the 
elderly.  This study used a questionnaire that simply asked participants about their intake of 
Caffeine Containing Foodstuffs (CCFS) (tea, coffee, chocolate and cola) four hours before 
testing. An interaction effect of age and intake of CCFS prior to neuropsychological 
assessment was found on six of the nine assessments used whereby the older elderly (over 
approximately the age of 80) performed significantly worse if they had consumed CCFS and 
the younger elderly performed significantly better if they had consumed CCFS.  It remained 
unclear whether it is the caffeine contained within these foodstuffs causing the interaction 
effect or whether it is because of other substances in CCFS. For example, coffee also contains 
chlorogenic acid, cafestol and kahweol [1] and tea is concentrated in polyphenols which have 
been shown to enhance memory [2].  Furthermore, Walters and Lesk [7] found an interaction 
effect between 200mg of caffeine, the time of day assessments were administered and scores 
on the Mini Mental State Examination (MMSE)[8] and Graded Naming Test (GNT) [9]. The 
present study analyses this data set further.  
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Materials and Methods 
The data set used in this paper is that used to investigate time of day effects and 
caffeine in Walters and Lesk [7].  The methods of data collection, tests used, inclusion 
criteria and procedure are described in detail there [7].  In the present study the aim is 
specifically to investigate whether prior caffeine and age influence performance on the same 
battery of cognitive tests. Forty participants from the University of Bradford, Division of 
Psychology cognitively-healthy elderly participant pool, were recruited to take part in the 
study.  Ethical approval was obtained from the Humanities, Social & Health Science 
Research Ethics Panel at the University of Bradford.  The study was performed double blind 
and there were an equal number of participants in both the placebo (n=20) and caffeine 
condition (n=20).   
A cognitive battery was administered to each participant in the same order which 
consisted of the MMSE [8], word recall [10], Stroop [11], Pattern Comparison Speed (PCS) 
[12], Letter Comparison Speed (LCS) [12], digit span [13]; Dual Tasks [14], SDMT [15] 
Cambridge Neuropsychological Test Automated Battery Paired Associates Learning 
(CANTAB PAL) [16] and GNT [9].  See Walters and Lesk [7]. 
Results 
The aim of the current study was to investigate whether 200 mg of prior caffeine can 
affect scores on  neuropsychological tests in a group of participants over the age of 60.  There 
were no main effects of gender or education on any of the tests administered and no main 
effect of drug group on any of the assessments used. 
Following on from Lesk et al. [6], to assess formally whether prior caffeine 
consumption has an effect on performance with increasing age, all cognitive tests were 
submitted to a multivariate analysis of covariance (MANCOVA) with drug group (caffeine or 
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placebo) entered  into the model as a fixed factor and age as a covariate.  An interaction term 
was included in the model. The results of this analysis can be seen in table 1.  Significant 
interactions between caffeine/placebo, age and scores on the SDMT, Dual Task Ratio, Dual 
Tasks T1-T2 interval, Stroop Interference, the PCS and LCS were found.  No significant 
interaction effect is seen for the MMSE, digit span and digit score, the PAL, the GNT, word 
recall or the Stroop colour. Figure 1 contains scatter plots of those test scores that showed a 
significant interaction between drug group and age.  There were no significant linear trends 
for the placebo group on any of the tests. Although there is no interaction between drug group 
and age for the GNT, a regression analysis did reveal a linear decrease in performance with 
age for those participants who received caffeine. 
Table 1: MANCOVA results for the interactions between age and drug group and the 
outcomes of the linear regression analysis for each group separately. 
       
       
Testing domain Assessment Caffeine Placebo p and η
2
 value of interaction 





       
       
General cognition MMSE 28.75±1.21 28.40±0.94 n.s. n.s. n.s. 
Episodic memory CANTAB PAL 6 errors 07.35±6.40 07.90±6.67 n.s. n.s. n.s. 
Semantic memory GNT 26.30±2.98 25.65±2.64 n.s. r = 0.44, p = 0.05 n.s. 
Working memory Digit Span 06.50±1.00 06.25±0.79 n.s. n.s. n.s. 
 Digit Score 08.95±1.82 08.60±1.64 n.s. n.s. n.s. 
Executive function Dual Tasks T1–T2 07.30±11.66 03.65±6.17 f(2, 37) = 6.51, p < 0.01, η
2 
=0.26 r = 0.49, p <0.05 n.s. 
 Dual Task ratio 00.92±0.22 00.10±0.12 f(2, 37) = 7.55, p < 0.01, η
2
 = 0.29 r = 0.64, p <0.05 n.s. 
 SDMT total correct 40.10±9.03 38.70±7.45 f(2, 37) = 6.67, p < 0.01, η
2
 = 0.27 r = 0.68, p < 0.01 n.s. 
 Stroop interference 30.05±10.92 25.80±9.02 f(2, 37) = 5.64, p < 0.01 , η
2
 = 0.23 r = 0.62, p < 0.01 n.s. 
Processing speed PCS 25.25±3.96 22.45±4.94 f(2, 37) = 3.65, p <0.05, η
2
 = 0.17 r = 0.56, p < 0.05 n.s. 
 LCS 15.35±3.72 12.80±2.95 f(2, 37) = 6.91, p < 0.01, η
2
 = 0.27 r = 0.58, p < 0.01 n.s. 
 Stroop colour 24.75±5.48 23.85±7.16 n.s. n.s. n.s. 
Short-term memory Word Recall 05.35±1.76 04.80±1.44 n.s. n.s. n.s. 
 
 
n.s. = Not significant. 
       
       
 




Figure 1: Scatter plots showing the interaction effects between caffeine x age and score for (A) Dual Task ratio, 
(B) Dual Tasks T1-T2 interval, (C) SDMT total correct responses, (D) Stroop Interference, (E) PCS and (F) 
LCS. There is a significant linear decrease in performance with increasing age for the caffeine group. A higher 
score for T1-T2 interval equates to poorer performance on this test.  





The aim of the present paper was to extend the results of Lesk et al. [6] by 
investigating whether 200mg of pure caffeine could influence score on cognitive tests in the 
over 60-year-old participants.  No main effect of caffeine or placebo was found on any of the 
tests administered.   Significant interaction effects between drug group, age and tests of 
executive function, (specifically the Dual Task ratio score and number of boxes crossed at 
time point one v time point two, the SDMT total score and the score for Stroop Interference) 
and processing speed, (specifically the scores on the LCS and PCS tasks) were found.  The 
third test for processing speed, the Stroop colour test, did not show the same interaction 
effects. In the tests that showed this interaction, for the caffeine subgroup, participants’ scores 
declined with increasing age, an effect not seen in the placebo condition.   
The present study and Lesk et al.[6], both show that if there is no caffeine in the 
system (no prior consumption of CCFS in Lesk et al. [6] and the placebo condition in this 
study) the results are the most controlled i.e. no significant interaction and no main effects in 
the regression analysis.  One strong advantage of this study is that it focuses specifically on 
caffeine and no other CCFS showing that the effects are because of caffeine.  The 
discrepancies between the two studies may therefore be because of the other components 
within CCFS [1,2,17]. This raises the question of whether participants should be asked to 
abstain from caffeine and CCFS for at least four hours before being given any 
neuropsychological assessment 
Significant interactions in this cohort were only found on tests of EF executive 
function and processing speed which has implications for the diagnostic process of 
Alzheimer’s disease.  It is not possible to determine the specific reasons for the selectivity of 
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the effects of caffeine to these particular cognitive domains from the present data.   
 Executive function is specifically associated with the frontal lobes [18,19], which are 
highly susceptible to age-related changes compared to other areas associated with cognitive 
function [19,20,21].  Furthermore, caffeine is an adenosine receptor antagonist [22]. During 
aging, adenosine receptors are specifically upregulated in frontal cortex [23]. This may 
explain why the effects of caffeine alter with age in relation to executive function skills.  This 
highlights the need to control for prior caffeine intake in neuropsychological assessment.  
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